Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City

Abstract Severe mpox has been observed in people with advanced human immunodeficiency virus (HIV). We describe clinical outcomes of 13 patients with advanced HIV (CD4

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2024-06, Vol.11 (6), p.ofae294
Main Authors: Garcia, Elizabeth A, Foote, Mary M.K, McPherson, Tristan D, Lash, Maura K, Bosompem, Amma N, Bouscaren, Alyssa, Chan, Justin, DiLorenzo, Madeline A, Feihel, Dennis, Fowler, Randal C, Gandhi, Vani, Jenny-Avital, Elizabeth R, Kopping, Erik J, Mazo, Dana, McLean, Jacob, Mgbako, Ofole, Sayegh, Mark N, Shaw, Raphael N, Su, Michelle, Meissner, Jeanne Sullivan, Wang, Jade C, Wen, Wendy, Winters, John C, Zeana, Cosmina B, Zucker, Jason, Wong, Marcia
Format: Article
Language:English
Subjects:
Drug approval
HIV (Viruses)
Hospital patients
Infectious Diseases in Special Populations
Medical colleges
Trifluridine
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Severe mpox has been observed in people with advanced human immunodeficiency virus (HIV). We describe clinical outcomes of 13 patients with advanced HIV (CD4
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofae294